STOCK TITAN

Alkermes to Report Fourth Quarter and Year-End 2021 Financial Results on Feb. 16, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) will conduct a conference call on February 16, 2022, at 8:00 a.m. ET to discuss its fourth quarter and year-end 2021 financial results. The call will provide insights into the company's financial expectations for 2022 and include an operational update. Investors can access the webcast and slides via the Investors section on Alkermes' website. Dial-in details for U.S. and international callers are provided. A replay will be available shortly after the event.

Positive
  • None.
Negative
  • None.

DUBLIN, Feb. 2, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Wednesday, Feb. 16, 2022 to discuss the company's fourth quarter and year-end 2021 financial results. Management will also discuss financial expectations for 2022 and provide an update on the company.

The webcast player and accompanying slides may be accessed on the Investors section of Alkermes' website at www.alkermes.com. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers. A replay of the webcast will be available approximately two hours after the completion of the event and may be accessed by visiting Alkermes' website. 

About Alkermes plc
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes Contact:
Alex Braun
Investor Relations
+1 781 296 8493

Alkermes plc Logo (PRNewsfoto/Alkermes plc)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-report-fourth-quarter-and-year-end-2021-financial-results-on-feb-16-2022-301473541.html

SOURCE Alkermes plc

FAQ

When will Alkermes report its fourth quarter and year-end 2021 financial results?

Alkermes will report its financial results on February 16, 2022.

What time is Alkermes' conference call on February 16, 2022?

The conference call is scheduled for 8:00 a.m. ET.

How can I access the Alkermes conference call?

You can access the call by dialing +1 877 407 2988 for U.S. callers or +1 201 389 0923 for international callers.

Is there a way to replay the Alkermes call after it concludes?

Yes, a replay of the conference call will be available approximately two hours after the event on Alkermes' website.

What will be discussed in Alkermes' February 16, 2022, conference call?

The call will discuss the fourth quarter and year-end 2021 financial results, as well as financial expectations for 2022.

Alkermes Inc. plc

NASDAQ:ALKS

ALKS Rankings

ALKS Latest News

ALKS Stock Data

4.77B
169.22M
1.33%
113.13%
9.78%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
DUBLIN 4